pharmaphorum

AUGUST 21, 2022

There’s no word yet on its pricing, but for comparison Spravato was launched with an annual price tag of around $32,400, which the Institute for Clinical and Economic Review (ICER) concluded was around 25% to 52% too high to be cost effective. Following after is AXS-12 (reboxetine) for narcolepsy, which could be filed in 2023.

Drugs 98

Drugs FDA Approval Production Marketing 98

pharmaphorum

OCTOBER 21, 2021

Vounatsos also insisted that Aduhelm’s price tag has not been a factor discouraging treatment with the drug. Biogen stumped up $1.525 billion upfront for rights to the drug and another Sage candidate for neurological diseases last year, when the expectation was that Aduhelm was unlikely to get FDA approval.

Sales 120

Sales Doctors Doctor Gene Therapy 120

Pharmaceutical Technology

JUNE 29, 2022

For example, while orphan drug designations have more than doubled in the last decade compared to the previous one, only 16% of therapies with orphan tags have managed to gain FDA approval in some indications.

Drugs 246

Drugs FDA Approval Marketing Development 246

pharmaphorum

JULY 25, 2022

The new drug is one of two bispecifics for multiple myeloma in the late-stage pipeline of J&J’s Janssen division stemming from its longstanding and fertile collaboration with Danish biotech Genmab, along with talquetamab which binds to CD3 and GPRC5D. .”

Antibody 52

Antibody Medicine Drugs Trials 52

Delveinsight

FEBRUARY 23, 2021

The company plans to use the capital to expand its pipeline of protein-based vaccines and biologic cancer therapies utilizing its innovative and proprietary Trimer-Tag technology platform. The company develops transformative biologics including vaccines and therapeutics for the world’s most debilitating diseases.

In-Vitro 52

In-Vitro Vaccination Vaccine Licensing 52

XTalks

AUGUST 17, 2020

With several biologics in the pipeline, including one in early stage clinical trials for head and neck cancer, the company is positioned to engineer highly specific biologics against immune targets in the body. The third asset in the pipeline targets a mutated epitope of KRAS, which is a primary tumor driver. Neo-STAT Platform.

Protein 98

Protein Engineer Immune Response In-Vivo 98

pharmaphorum

DECEMBER 2, 2020

For all the latest Pfizer news follow pharmaphorum’s Pfizer tag. With fingers in every pie, ranging from small molecules to biologics in every clinical area, to stem cells and consumer goods, Pfizer will surely celebrate its 200th anniversary in as strong a position as it spent the last 160 years.

Sales 127

Sales Production Drugs Marketing 127

XTalks

AUGUST 19, 2022

Bluebird has a total of three gene therapies in its pipeline. Zynteglo’s hefty price tag of $2.8 Zynteglo’s weighty price tag posed to be an issue in Europe, with bluebird having to pull the drug shortly after it was approved in the EU due to both issues with securing reimbursement payment plans, and manufacturing problems.

Gene Therapy 95

Gene Therapy FDA Approval Gene Clinical Trials 95

Delveinsight

JULY 22, 2020

The hospital inventory is equipped with tagged sensors. Several tech devices are in the pipeline with advanced features and applications such as wristbands, watches, patches, socks, shoes, contact lenses, and many others. Medical Equipment Tracking. IoT can also be utilised in equipment tracking and management.

Doctors 59

Doctors Doctor Marketing Production 59

XTalks

AUGUST 23, 2021

More than 125 drugs are still in the [Alzheimer’s disease] drug development pipeline,” said Dr. Grill. With a $56,000 price tag for a year’s worth of treatment, Aduhelm is far from the most expensive drug on the market. Managing Patient Attrition in Ongoing Alzheimer’s Clinical Trials. Will they drop out to take it?

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drugs 52

pharmaphorum

FEBRUARY 26, 2021

The company brought with it a group of medicines that treat pulmonary arterial hypertension – well-established blockbuster Tracleer (bosentan), and the more recently-approved Opsumit (macitentan) and Uptravi (selexipag), as well as a slew of pipeline products. . And at the tail end of 2020, a $6.5 COVID and beyond.

Sales 125

Sales Production Pharma Companies Marketing 125

Delveinsight

DECEMBER 3, 2020

It has been speculated that modifications to the epigenome drive cell ageing, especially a process known as DNA methylation, by which methyl groups are tagged onto DNA. Bayer has made a cell and gene therapy platform to assist its growing pipeline of advanced therapy medicinal products. Bayer creates cell and gene therapy platform.

Gene Therapy 52

Gene Therapy Gene Antibody Research 52

Drug Discovery World

FEBRUARY 21, 2023

Pillai works directly with scientists to onboard new assays onto robotic platforms, to improve data pipelines for new instruments and metadata capture, and to enable new technologies for scientists to execute on their lab work more efficiently. There is also an issue with metadata during experiments.

Scientist 52

Scientist Gene Editing Engineer Bioinformatics 52

XTalks

MARCH 22, 2023

Our webinars have become a key vendor-selection tool for decision-makers across the drug development pipeline — from discovery to commercialization — which is why all ten of the top ten contract research organizations (CROs) have worked with Xtalks.

Life Science 97

Life Science Drugs FDA Approval Vaccination 97

Drug Discovery World

NOVEMBER 13, 2023

Christopher Rowley, PhD, Principal Research Scientist, Protein Science Pipeline, Immunocore, on: ‘ImmTAC: A high-affinity soluble TCR bispecific platform to target cancers’. Fabian Mohr, PhD, Vice President Research & Development, IBA Lifesciences, on: ‘Developing a robust affinity tag platform using engineered streptavidin’.

Protein 59

Protein Antibody Engineer Scientist 59

Drug Discovery World

NOVEMBER 9, 2023

Esperanza Rivera de Torre, PhD, Assistant Professor, Center for Antibody Technologies, Department of Bioengineering, Technical University of Denmark, on: ‘Venom on demand: optimising snake toxin yield, folding, and purity in E coli and P pastoris with biotinylation, solubility, and purification tags’. Crystal Richardson, Ph.D,

Engineer 52

Engineer Antibody Protein In-Vivo 52

Drug Discovery World

OCTOBER 21, 2022

The main principle involves a well-defined light source such as that produced by lasers that excites fluorescent tags bound to the cells or particles present in a sample. A major breakthrough in the technology was the development of biologically active fluorescent reagents that could be detected by the instruments.

Reagent 52

Reagent Antibody Drugs Protein 52

The Pharma Data

MAY 4, 2021

In addition, we have achieved important clinical, regulatory and commercial milestones across our pipeline and portfolio while also continuing to increase our capacity to supply urgently-needed doses of BNT162b2 to the world. Pipeline Developments. The full report can be found at Pfizer.com/ESG_Report. Amy Rose 212.733.7410.

Vaccination 40

Vaccination Vaccine Production Sales 40